Showing matches for development code — no filters applied1 results shown

Program Matched

VIR-5500

Vir Biotechnology, Inc. / Astellas

VIR-5500 by Vir Biotechnology, Inc.. PHASE1 trial in Hormone-refractory Prostate Cancer.

Hormone-refractory Prostate Cancer

Studies (1 shown)

NCT05997615PHASE1RECRUITING

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Sponsor · Vir Biotechnology, Inc.Condition · Hormone-refractory Prostate CancerIntervention · VIR-5500, EnzalutamideUpdated Apr 2026
Showing top 1 results. See all 1 results on CT.gov →